This page contains a Flash digital edition of a book.
MEDICINE MANAGEMENT


David Pruce, director of PruceConsulting and former Director of Policy & Communications at The Royal Pharmaceutical Society, explores the clinical and fi nancial cost of non-adherence among dementia sufferers.


T


he problem of patients not adhering to medicine regimes is a costly one


for the NHS; not only does it compromise health outcomes, it puts the public purse under strain. Between a third and half of all medicines are not taken as recommended, resulting in between £36m and £196m- worth of preventable hospital admissions.1 For Britain’s 614,000 dementia sufferers,2 complying with doctors’ orders is an even greater challenge.


At a recent GP Commissioning Conference, NHS chief executive Sir David Nicholson underlined that for ‘the new NHS’ the onus is on caring for patients in their own home wherever possible. Indeed, practice man- ager Jose Tarnowski explained that a day’s admission to an acute hospital costs the same as a whole year’s care by a GP prac- tice.


While in-home care is a priority for NHS reforms, taking dementia sufferers away from a hospital or caring environment where medication can be administered and monitored dramatically increases the risk and cost of non-adherence. So with the NHS looking to make its drug budget work harder, what challenges do dementia sufferers face in complying with medicine regimes? And how can we overcome them (cost) effectively?


Keeping it simple


Memory loss is the greatest obstacle to ad- herence for patients with dementia. The fact that many dementia sufferers take a range of medicines to treat multiple condi- tions exacerbates the situation. Prescribers can encourage greater adherence by reduc- ing the number of medicines taken and the number of doses required each day. This in- volves reviewing the need for a medicine or using combination products containing two or more medicines in one tablet.


Historically, these products have been frowned upon because they are gener-


64 | national health executive Jul/Aug 11


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84